Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New therapeutic agents for gastrointestinal disorders disclosed in recent patents

Nov. 2, 2006

Stelic discovers new treatment approach for acute liver failure

Nov. 2, 2006

Crofelemer studied for D-IBS in new phase IIb trial

Nov. 2, 2006

Pentoxifylline assessed in clinical trials in liver diseases

Nov. 2, 2006

R-1626 shows promise in hepatitis C

Nov. 2, 2006

R-7128 begins phase I study for HCV

Oct. 31, 2006

Interferon alfacon-1/ribavirin shows promise in HCV peg-interferon nonresponders

Oct. 31, 2006

Studies detail long-term hepatitis B viral suppression with telbivudine

Oct. 31, 2006

Bavituximab safe in phase I hepatitis C study

Oct. 31, 2006

Long-term hepatitis C virus suppression seen with valopicitabine and peg-interferon

Oct. 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...